The benefits of GLP-1 drugs beyond obesity
Daniel J. Drucker
Abstract
Glucagon-like peptide-1-based medicines have weight loss-independent actions.
Topics & Concepts
Glucagon-like peptide-1Weight lossObesityAnti obesityGlucagonPharmacologyExenatideMedicineChemistryEndocrinologyDiabetes mellitusType 2 diabetesInsulinDiabetes Treatment and ManagementPharmacology and Obesity TreatmentDiet and metabolism studies